loader2
Login OPEN ICICI 3-in-1 Account

Jul 11, 2025

loader2

Open ICICI
3-in-1 Account

Manage your Savings, Demat and Trading Account conveniently at one place

Incur '0' Brokerage upto ₹500

What is Nifty 200?

Company Name PE Mcap/Sales P/BV EV/EBIDTA D/E ROCE ROE
Abbott India Ltd 51.70 12.45 0.06 48.70 0.03 44.71 34.88
Cipla Ltd 23.31 4.35 0.26 17.15 0.02 23.15 18.28
J B Chemicals & Pharmaceuticals Ltd 38.06 7.20 0.14 31.65 0.18 24.90 20.45
Dr Reddys Laboratories Ltd 18.86 3.21 0.32 12.88 0.11 23.05 18.53
Lupin Ltd 26.34 4.32 0.20 25.30 0.28 15.34 14.47
Torrent Pharmaceuticals Ltd 58.54 9.74 0.07 35.00 0.50 25.84 26.46
Ipca Laboratories Ltd 42.01 5.51 0.19 27.47 0.16 17.21 12.39
Sun Pharmaceutical Industries Ltd 35.03 7.63 0.18 25.96 0.04 19.52 16.16
Aurobindo Pharma Ltd 18.90 2.27 0.50 12.61 0.21 13.51 11.18
Natco Pharma Ltd 9.14 4.31 0.44 9.12 0.05 29.63 25.88
Granules India Ltd 23.74 2.52 0.33 17.78 0.40 15.22 13.38
Ajanta Pharma Ltd 35.82 7.06 0.12 25.58 0.01 31.98 25.02
Gland Pharma Ltd 43.85 5.41 0.30 20.16 0.02 13.44 9.26
Biocon Ltd 53.14 3.39 0.52 27.31 0.91 6.35 6.89
Alkem Laboratories Ltd 26.54 4.54 0.21 24.41 0.15 18.29 18.72
Glenmark Pharmaceuticals Ltd 46.70 5.21 0.14 0.00 0.34 12.05 -50.87
Zydus Lifesciences Ltd 21.11 5.04 0.24 17.47 0.05 23.94 20.64
Divis Laboratories Ltd 82.80 23.12 0.08 86.66 0.00 16.41 12.15
Mankind Pharma Ltd 53.56 10.30 0.13 42.57 0.02 27.91 23.12
Laurus Labs Ltd 133.40 7.69 0.10 44.09 0.62 8.80 7.36

Other Indices

INDEX NAME MARKET VALUE 52W HIGH 52W LOW
Nifty Next 50 67965.55
(-0.8142%)
77918.0 56192.45
Nifty Bank 56754.70
(-0.3534%)
57628.40 47702.90
Nifty 50 25149.85
(-0.8101%)
26277.35 21743.65
Nifty 100 25760.80
(-0.8107%)
27335.65 22177.35
BSE SmallCap 54484.76
(-0.6997%)
57827.69 41013.68
BSE Sensex 82500.47
(-0.8292%)
85978.25 71425.01
BSE MidCap 46291.20
(-0.6480%)
49701.15 37203.21
BSE 100 26354.28
(-0.8494%)
27762.24 22539.11

Nifty Pharma

The NIFTY Pharma Index reflects the behaviour and performance of the pharmaceutical sector in India. The index has a maximum of 20 stocks since the last amendment effective from 30th September 2021. The NIFTY Pharma stocks are calculated using the free-float market capitalization method and can be used for benchmarking fund portfolios, among other utilization for investors. The index was launched in July 2005; the base date being 1st January 2001 with a base value of 1000. Index is re-balanced on semi-annual basis. The cut-off date is January 31 and July 31 of each year. When rebalancing, the weightage of each stock in the index is calculated such that no single stock has a weightage of more than 33%, and that of top 3 stocks cumulatively shall not be more than 62%.

News

Prataap Snacks fixes record date for dividend

Prataap Snacks has fixed 31 July 2025 as record date for the purpose of determining the entitlement of...

Jul 12, 2025 12:45
TD Power Systems fixes record date for final dividend

TD Power Systems has fixed 30 July 2025 as record date to ascertain members entitled to receive final d...

Jul 12, 2025 12:41
Aeroflex Industries fixes record date for final dividend

Aeroflex Industries has fixed 29 July 2025 as record date for the purpose of determining the entitlemen...

Jul 12, 2025 12:39
Shree Cement fixes record date for final dividend

Shree Cement has fixed 21 July 2025 as record date for determining entitlement of members to final divide...

Jul 12, 2025 12:31
Bright Outdoor Media fixes record date for bonus issue

Bright Outdoor Media has fixed 18 July 2025 as record date for bonus issue. Capit...

Jul 12, 2025 12:29
AstraZeneca Pharma fixes record date for final dividend

AstraZeneca Pharma India has fixed 18 July 2025 as record date for final dividend for FY 2024-25. The div...

Jul 12, 2025 12:25

Explore ETF

Disclaimer

ICICI Securities Ltd.( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Mumbai - 400025, India, Tel No:- 022 - 2288 2460, 022 - 2288 2470. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code:-07730) and BSE Ltd (Member Code :103) and having SEBI registration no. INZ000183631. SEBI research analyst Registration no.-INH000000990. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest.  I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The non-broking products / services like Mutual Funds, Insurance, FD/ Bonds, loans, PMS, Tax, Elocker, NPS, IPO, Research, Financial Learning etc. are not exchange traded products / services and ICICI Securities Ltd. is just acting as a distributor/ referral Agent of such products / services and all disputes with respect to the distribution activity would not have access to Exchange investor redressal or Arbitration mechanism.